TREATMENT AND PROGNOSIS OF METASTATIC CARCINOMA OF UNKNOWN PRIMARY - ANALYSIS OF 100 PATIENTS

被引：22

作者：

ALBERTS, AS

FALKSON, G

FALKSON, HC

VANDERMERWE, MP

机构：

[1] UNIV PRETORIA, DEPT MED ONCOL, PRIVATE BAG X169, PRETORIA 0001, SOUTH AFRICA

[2] S AFRICAN MRC, INST BIOSTAT, PRETORIA, SOUTH AFRICA

来源：

MEDICAL AND PEDIATRIC ONCOLOGY | 1989年 / 17卷 / 03期

关键词：

D O I：

10.1002/mpo.2950170304

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：188 / 192

页数：5

共 14 条

[1]

COX DR, 1972, J R STAT SOC B, V34, P187

[2] METASTATIC CARCINOMAS FROM OCCULT PRIMARY TUMORS - STUDY OF 254 PATIENTS [J].

DIDOLKAR, MS ;

FANOUS, N ;

ELIAS, EG ;

MOORE, RH .

ANNALS OF SURGERY, 1977, 186 (05) :625-630

[3]

FALKSON G, 1981, CANCER CHEMOTH PHARM, V6, P31

[4]

FALKSON G, 1981, CANCER CLIN TRIALS, V4, P81

[5] 5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN IN THE TREATMENT OF ADENOCARCINOMA OF UNKNOWN PRIMARY [J].

GOLDBERG, RM ;

SMITH, FP ;

UENO, W ;

AHLGREN, JD ;

SCHEIN, PS .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) :395-399

[6] ADVANCED POORLY DIFFERENTIATED CARCINOMA OF UNKNOWN PRIMARY SITE - RECOGNITION OF A TREATABLE SYNDROME [J].

GRECO, FA ;

VAUGHN, WK ;

HAINSWORTH, JD .

ANNALS OF INTERNAL MEDICINE, 1986, 104 (04) :547-553

[7]

MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163

[8]

MOERTEL CG, 1972, CANCER-AM CANCER SOC, V30, P1469, DOI 10.1002/1097-0142(197212)30:6<1469::AID-CNCR2820300609>3.0.CO

[9]

2-T

[10] TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].

OKEN, MM ;

CREECH, RH ;

TORMEY, DC ;

HORTON, J ;

DAVIS, TE ;

MCFADDEN, ET ;

CARBONE, PP .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655

← 1 2 →